Electrolyte Abnormalities Associated With the Use of Atezolizumab – A Systematic Review

BACKGROUND AND OBJECTIVES: In recent years, immune-checkpoint inhibitors (ICIs) particularly atezolizumab is on the rise in treating advanced malignancies. With its increased clinical use, various electrolyte abnormalities have been reported in the literature. In this review, we have addressed the q...

Descripción completa

Detalles Bibliográficos
Autores principales: Rafae, Abdul, Ali, Sundas, Sana, Muhammad Khawar, Rana, Farhan Khalid, Ibrahim, Ahmed, Ahmed, Zahoor, Jan, Ali, Ehsan, Hamid, Fatima, Tehreem, Kunadi, Arvind
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Greater Baltimore Medical Center 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9195059/
https://www.ncbi.nlm.nih.gov/pubmed/35712686
http://dx.doi.org/10.55729/2000-9666.1037

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9195059/
https://www.ncbi.nlm.nih.gov/pubmed/35712686
http://dx.doi.org/10.55729/2000-9666.1037

Ejemplares similares